Loading...

Rheumatology

SLEDAI-2K

Calculator

Score:
Seizure

Recent onset. Exclude metabolic, infectious or drug cause

This field is required
Psychosis

Altered ability to function in normal activity due to severe disturbance in the perception of reality. Include hallucinations, incoherence, marked loose assoications, impoverished thought content, marked illogical thinking, bizarre disorganised or catatonic behaviour. Excluded uraemia and drug causes.

This field is required
Organic brain syndrome

Altered mental function with impared orientation, memory or other intelligent function, with rapid onset fluctuating clinical features. Include clouding of consciousness with reduced capacity to focus, and inability to sustain attention to environment, plus at least two of the following: perceptual disturbance, incoherent speech, insomnia or daytime drowsiness, or increased or decreased psychomoto activity. Exclude metabolic, infectious or drug causes.

This field is required
Visual disturbance

Retinal changes of SLE include cytoid bodies, retinal haemorrhages, serous exudate or haemorrhages in the choroids or optic neuritis. Exclude hypertension, infection or drug causes.

This field is required
Cranial nerve disorder

New onset of sensory or motor neuropathy involving cranial nerves.

This field is required
Lupus headache

Severe persistent headache: may be migrainous, but must be nonresponsive to narcotic analgesia.

This field is required
CVA

New onset of cerebrovascular accident(s). Exclude arteriosclerosis.

This field is required
Vasculitis

Ulceration, gangrene, tender finger nodules, periungual infarction, splinter haemorrhages, or biopsy/angiogram proof of vasculitis.

This field is required
Arthritis

More than 2 joints with pain and signs of inflammation (i.e. tenderness, swelling or effusion).

This field is required
Myositis

Proximal muscle aching/weakness, associated with elevated creatine phosphokinase/adolase or electromyogram changes or a biopsy showing myositis.

This field is required
Urinary casts

Haem-granular or red blood cell casts.

This field is required
Haematuria

More than 5 red blood cells/high power field. Exclude stone, infection or other cause.

This field is required
Proteinuria

More than 0.5g/24 hours. New onset or recent increase of more than 0.5g/24 hours

This field is required
Pyruia

More than 5 white blood cells/high power field. Exclude infection.

This field is required
New rash

New onset or recurrence of inflammatory type rash.

This field is required
Alopecia

New onset or recurrence of abnormal, patchy or diffuse loss of hair.

This field is required
Mucosal ulcers

New onset or recurrence of oral or nasal ulcerations.

This field is required
Pleurisy

Pleuritic chest pain with pleural rub or effusion or pleural thickening.

This field is required
Pericarditis

Pericardial pain with at least 1 of the following: rub, effusion or electrocardiogram confirmation.

This field is required
Low complement

Decrease in CH50, C3 or C4 below the lower limit of normal for testing laboratory.

This field is required
Increased DNA binding

More than 25% binding by Farr assay or above normal range of testing laboratory.

This field is required
Fever

More than 38℃. Exclude infectious cause.

This field is required
Thrombocytopenia

Less than 100,000 platelets/mm^3

This field is required
Leukopaenia

Less than 3000 white blood cell/mm^3. Exclude drug causes.

This field is required

SLEDAI-2K:


Considerations

The tool is for educational use only, is not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

  • These classification criteria should be applied to classify a patient as having eosinophilic granulomatosis with polyangiitis when a diagnosis of small- or medium-vessel vasculitis has been made
  • Alternate diagnoses mimicking vasculitis should be excluded prior to applying the criteria
Reference

Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP; OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 Dec 15;353(24):2550-8. doi: 10.1056/NEJMoa051135. PMID: 16354891.

Noticed an error with this calculator?

Help improve this page by telling me more about it

Please enter your name Please enter a valid email address Please enter subject Write us a message

Have an idea for a new calculator?

Let me know more about what you'd like to see

Please enter your name Please enter a valid email address Please enter subject Write us a message

Disclaimer

In Plain English:

MDG Medical cannot and will not be held legally, financially, or medically responsible for decisions made using its calculators, equations, content, and algorithms, and is for the use of medical professionals only. Double-check your work, and trust your clinical judgment over a number or result.

Official Legal Disclaimer

MDG Medical includes clinical tools and content intended for use by healthcare professionals. These tools do not give professional advice; physicians and other healthcare professionals who use these tools or databases should exercise their own clinical judgment as to the information they provide. Consumers (non-medical professionals) who use the tools or databases do so at their own risk. Individuals with any type of medical condition are specifically cautioned to seek professional medical advice before beginning any sort of health treatment. For medical concerns, including decisions about medications and other treatments, non-medical users users should always consult their physician or other qualified healthcare professional. MDG Medical’s content developers have carefully tried to create its content to conform to the standards of professional practice that prevailed at the time of development. However, standards and practices in medicine change as new data become available and the individual medical professional should consult a variety of sources. The contents of the MDG Medical site and apps, such as text, graphics, and images are for informational purposes only. MDG Medical does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the site. While information on this site has been obtained from sources believed to be reliable, neither we nor our content providers warrant the accuracy of the information contained on this site. We do not give medical advice, nor do we provide medical or diagnostic services. Medical information changes rapidly. Neither we nor our content providers guarantee that the content covers all possible uses, directions, precautions, drug interactions, or adverse effects that may be associated with any therapeutic treatments. Your reliance upon information and content obtained by you at or through this site is solely at your own risk. Neither we nor our content providers assume any liability or responsibility for damage or injury (including death) to you, other persons, or property arising from any use of any product, information, idea, or instruction contained in the content or services provided to you.

When content from original works is included on our site, we provide references (typically in our "Evidence" section) which are the intellectual property of their authors/publishers (or the public domain when appropriate). Our website transforms these works into interactive, dynamically-scored calculators that we believe to qualify for transformative fair use: from a static list to a live calculator with both the total score as well as diagnostic/prognostic information and recommendations. However, if you believe this use violates your copyright(s), please don’t hesitate to send us an email and we will remove the offending content.